Literature DB >> 22287610

Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

Helen Christou1, Ossama M Reslan, Virak Mam, Alain F Tanbe, Sally H Vitali, Marlin Touma, Elena Arons, S Alex Mitsialis, Stella Kourembanas, Raouf A Khalil.   

Abstract

Pulmonary hypertension (PH) is characterized by pulmonary arteriolar remodeling with excessive pulmonary vascular smooth muscle cell (VSMC) proliferation. This results in decreased responsiveness of pulmonary circulation to vasodilator therapies. We have shown that extracellular acidosis inhibits VSMC proliferation and migration in vitro. Here we tested whether induction of nonhypercapnic acidosis in vivo ameliorates PH and the underlying pulmonary vascular remodeling and dysfunction. Adult male Sprague-Dawley rats were exposed to hypoxia (8.5% O(2)) for 2 wk, or injected subcutaneously with monocrotaline (MCT, 60 mg/kg) to develop PH. Acidosis was induced with NH(4)Cl (1.5%) in the drinking water 5 days prior to and during the 2 wk of hypoxic exposure (prevention protocol), or after MCT injection from day 21 to 28 (reversal protocol). Right ventricular systolic pressure (RVSP) and Fulton's index were measured, and pulmonary arteriolar remodeling was analyzed. Pulmonary and mesenteric artery contraction to phenylephrine (Phe) and high KCl, and relaxation to acetylcholine (ACh) and sodium nitroprusside (SNP) were examined ex vivo. Hypoxic and MCT-treated rats demonstrated increased RVSP, Fulton's index, and pulmonary arteriolar thickening. In pulmonary arteries of hypoxic and MCT rats there was reduced contraction to Phe and KCl and reduced vasodilation to ACh and SNP. Acidosis prevented hypoxia-induced PH, reversed MCT-induced PH, and resulted in reduction in all indexes of PH including RVSP, Fulton's index, and pulmonary arteriolar remodeling. Pulmonary artery contraction to Phe and KCl was preserved or improved, and relaxation to ACh and SNP was enhanced in NH(4)Cl-treated PH animals. Acidosis alone did not affect the hemodynamics or pulmonary vascular function. Phe and KCl contraction and ACh and SNP relaxation were not different in mesenteric arteries of all groups. Thus nonhypercapnic acidosis ameliorates experimental PH, attenuates pulmonary arteriolar thickening, and enhances pulmonary vascular responsiveness to vasoconstrictor and vasodilator stimuli. Together with our finding that acidosis decreases VSMC proliferation, the results are consistent with the possibility that nonhypercapnic acidosis promotes differentiation of pulmonary VSMCs to a more contractile phenotype, which may enhance the effectiveness of vasodilator therapies in PH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287610      PMCID: PMC3362160          DOI: 10.1152/ajplung.00293.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  80 in total

1.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension.

Authors:  D Dunbar Ivy; Ivan F McMurtry; Kelley Colvin; Masatoshi Imamura; Masahiko Oka; Dong-Seok Lee; Sarah Gebb; Peter Lloyd Jones
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

4.  Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.

Authors:  H Itoh; A Yokochi; R Yamauchi-Kohno; K Maruyama
Journal:  Eur J Pharmacol       Date:  1999-07-09       Impact factor: 4.432

5.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Marc Humbert; Xavier Jaïs; Vincent Ioos; Abdul M Hamid; Steeve Provencher; Gilles Garcia; Florence Parent; Philippe Hervé; Gérald Simonneau
Journal:  Circulation       Date:  2005-06-06       Impact factor: 29.690

7.  Extracellular acidosis induces heme oxygenase-1 expression in vascular smooth muscle cells.

Authors:  Helen Christou; Nicole Bailey; Morgan S Kluger; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-28       Impact factor: 4.733

8.  Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats.

Authors:  Mike L Green; Marguerite Hatch; Robert W Freel
Journal:  Am J Physiol Renal Physiol       Date:  2005-04-26

9.  Goal-oriented treatment and combination therapy for pulmonary arterial hypertension.

Authors:  M M Hoeper; I Markevych; E Spiekerkoetter; T Welte; J Niedermeyer
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

Review 10.  The influence of sex hormones on pulmonary vascular reactivity: possible vasodilator therapies for the treatment of pulmonary hypertension.

Authors:  A M Smith; R D Jones; K S Channer
Journal:  Curr Vasc Pharmacol       Date:  2006-01       Impact factor: 2.719

View more
  9 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Authors:  Helen Christou; Hannes Hudalla; Zoe Michael; Evgenia J Filatava; Jun Li; Minglin Zhu; Jose S Possomato-Vieira; Carlos Dias-Junior; Stella Kourembanas; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2017-12-06       Impact factor: 4.030

3.  Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension.

Authors:  Ya-Yun Wang; Yun Luan; Xue Zhang; Mei Lin; Zhao-Hua Zhang; Xiao-Bo Zhu; Yu Ma; Yi-Biao Wang
Journal:  Clin Exp Med       Date:  2013-06-16       Impact factor: 3.984

4.  Acidosis prevents and alkalosis augments endothelium-dependent contractions in mouse arteries.

Authors:  Oliver Baretella; Aimin Xu; Paul M Vanhoutte
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

5.  Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.

Authors:  Hannes Hudalla; Zoe Michael; Nicolas Christodoulou; Gareth R Willis; Angeles Fernandez-Gonzalez; Evgenia J Filatava; Paul Dieffenbach; Laura E Fredenburgh; Robert S Stearman; Mark W Geraci; Stella Kourembanas; Helen Christou
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 7.748

6.  Carbonic anhydrase inhibition improves pulmonary artery reactivity and nitric oxide-mediated relaxation in sugen-hypoxia model of pulmonary hypertension.

Authors:  Helen Christou; Zoe Michael; Fotios Spyropoulos; Yunfei Chen; Dan Rong; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-07       Impact factor: 3.210

7.  Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension.

Authors:  Aimilia Eirini Papathanasiou; Fotios Spyropoulos; Zoe Michael; Kyoung E Joung; Despina D Briana; Ariadne Malamitsi-Puchner; Christos S Mantzoros; Helen Christou
Journal:  Int J Mol Sci       Date:  2021-02-01       Impact factor: 5.923

8.  Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.

Authors:  Olga Sadowska; Marta Baranowska-Kuczko; Anna Gromotowicz-Popławska; Michał Biernacki; Aleksandra Kicman; Barbara Malinowska; Irena Kasacka; Anna Krzyżewska; Hanna Kozłowska
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

9.  Acetazolamide Improves Right Ventricular Function and Metabolic Gene Dysregulation in Experimental Pulmonary Arterial Hypertension.

Authors:  Fotios Spyropoulos; Zoe Michael; Benjamin Finander; Sally Vitali; Kosmas Kosmas; Panagiotis Zymaris; Brian T Kalish; Stella Kourembanas; Helen Christou
Journal:  Front Cardiovasc Med       Date:  2021-06-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.